What is Krystal Biotech, Inc.'s accrued inventory?

Krystal Biotech, Inc. (KRYS) reported accrued inventory of $1.04M in Q1 2026.

How has Krystal Biotech, Inc.'s accrued inventory changed year-over-year?

Krystal Biotech, Inc.'s accrued inventory decreased by 21.3% year-over-year, from $1.32M to $1.04M.

What is the long-term trend for Krystal Biotech, Inc.'s accrued inventory?

Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s accrued inventory has grown at a 73.5% compound annual growth rate (CAGR), from $334K to $1.01M.

Krystal Biotech, Inc. KRYS Accrued inventory

Other financials

Income statement

See full

Revenue$116.4M+31.9%

Operating income$53.7M+48.1%

Net income$55.9M+56.5%

EPS (diluted)$1.83+52.5%

Balance sheet

See full

Cash & equivalents$501.3M+62.4%

Total debt$9.1M-5.7%

Total equity$1.3B+29.7%

Total assets$1.4B+30.0%

Cash flow

See full

Operating cash flow$80.4M+160%

CapEx$7.1M+15.2%

Free cash flow$73.2M+196%

Valuation

See full

Market cap$10.26B+45.4%

Enterprise value$9.77B+44.2%

P/E45.6×-11.3×

P/S24.6×+3.4×

Profitability

See full

Operating margin42.8%+10.2pp

Net margin53.9%+16.7pp

FCF margin56.9%+16.5pp

Returns & leverage

See full

Return on equity19.9%+6.0pp

Debt / equity0×0.0×

Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept krys:AccruedInventory.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s accrued inventory.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s accrued inventory?: Krystal Biotech, Inc. (KRYS) reported accrued inventory of $1.04M in Q1 2026.
How has Krystal Biotech, Inc.'s accrued inventory changed year-over-year?: Krystal Biotech, Inc.'s accrued inventory decreased by 21.3% year-over-year, from $1.32M to $1.04M.
What is the long-term trend for Krystal Biotech, Inc.'s accrued inventory?: Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s accrued inventory has grown at a 73.5% compound annual growth rate (CAGR), from $334K to $1.01M.